A Randomised Phase II Trial of Osimertinib with or without Stereotactic Radiosurgery for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases

Project: Research

Project Details

StatusActive
Effective start/end date20/03/1919/03/24

Keywords

  • clinical trial
  • treatment efficacy
  • lung cancer
  • phase 2 trial